Arunjyoti Bio Ventures Ltd.

Arunjyoti Bio Ventures Ltd.

BBSE:ABVL
4.22
INR
-0.08
(-1.86%)
-0.33EPS
1.02BMarket Cap

Total Valuation

INR

As of June 30, 2026, Arunjyoti Bio Ventures Ltd. carries a market capitalization of 1.02B, placing it among publicly traded companies globally. Its enterprise value stands at 1.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.02B
Enterprise Value1.02B

Share Statistics

As of June 30, 2026, Arunjyoti Bio Ventures Ltd. has 186.38M shares outstanding.

Shares Outstanding186.38M

Valuation Ratios

These figures are as of June 30, 2026.

PS Ratio3.65

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 3.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.02B versus a market cap of 1.02B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.74

Financial Position

These figures are as of June 30, 2026.

Interest Coverage-0.73

Financial Efficiency

INR

These figures cover the twelve months ended June 30, 2026. The company generates approximately 1.63M in revenue per employee across its workforce of 167.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee1.63M
Employee Count167.00

Taxes

INR

Over the twelve months ended June 30, 2026, Arunjyoti Bio Ventures Ltd. recorded an income tax benefit of -5.22M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -64.91M and -59.67M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-5.22M

Stock Price Statistics

INR

As of the close on October 19, 2026, Arunjyoti Bio Ventures Ltd.'s stock has declined approximately 64.33% over the past 52 weeks. The 50-day moving average sits at 4.62, while the 200-day moving average is 6.25.

52-Week Price Change-64.33%
50-Day Moving Average4.62
200-Day Moving Average6.25

Income Statement

INR

Over the twelve months ended June 30, 2026, Arunjyoti Bio Ventures Ltd. generated 272.42M in revenue and converted that into -59.67M in net income, yielding earnings per share of -0.33. EBITDA reached -13.65M, while operating income came in at -20.13M.

Revenue272.42M
Gross Profit248.32M
Operating Income-20.13M
Pretax Income-64.91M
Net Income-59.67M
EBITDA-13.65M
EBIT-47.49M
Earnings Per Share (EPS)-0.33

Margins

Over the twelve months ended June 30, 2026, Arunjyoti Bio Ventures Ltd. posted a gross margin of 91.15, reflecting its pricing power and cost economics. The operating margin of -7.39 and net profit margin of -21.90 provide insight into operational efficiency.

Gross Margin91.15
Operating Margin-7.39
Pretax Margin-23.83
Profit Margin-21.90
EBITDA Margin-5.01

Stock Splits

Arunjyoti Bio Ventures Ltd.'s most recent stock split took place on January 17, 2025 with a 1:10 split ratio.

Last Split Date1/17/2025
Split Ratio1:10